Worcester, MA
United States
University of Massachusetts Worcester - Division of Endocrinology
RET mutation, RET fusion, oncogenic fusion, pheochromocytoma, paraganglioma, tyrosine kinase inhibitor, GRB2, driver genetic events, selpercatinib, pralsetinib